Bioceres Is Approaching Distressed Prices, But I Remain On The Sidelines

Bioceres Crop Solutions Corp. (NASDAQ: BIOX ) reported a disappointing Q2 2025 , with revenues down 24%. This was entirely driven by weakness in Argentina, its primary market. International sales improved, but they were nowhere near enough toLong-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics and future price action. Instead, our articles focus on operational aspects, understanding the long-term earnings power of co ...